These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 32104451)
1. Cyclodextrin/chitosan nanoparticles for oral ovalbumin delivery: Preparation, characterization and intestinal mucosal immunity in mice. He M; Zhong C; Hu H; Jin Y; Chen Y; Lou K; Gao F Asian J Pharm Sci; 2019 Mar; 14(2):193-203. PubMed ID: 32104451 [TBL] [Abstract][Full Text] [Related]
2. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666 [TBL] [Abstract][Full Text] [Related]
3. Chitosan nanoparticle antigen uptake in epithelial monolayers can predict mucosal but not systemic in vivo immune response by oral delivery. Cole H; Bryan D; Lancaster L; Mawas F; Vllasaliu D Carbohydr Polym; 2018 Jun; 190():248-254. PubMed ID: 29628245 [TBL] [Abstract][Full Text] [Related]
4. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination. Slütter B; Jiskoot W J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405 [TBL] [Abstract][Full Text] [Related]
5. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Elmoghayer ME; Saleh NM; Abu Hashim II Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733 [TBL] [Abstract][Full Text] [Related]
6. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity. Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018 [TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Khalil SK; El-Feky GS; El-Banna ST; Khalil WA Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738 [TBL] [Abstract][Full Text] [Related]
9. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies. Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980 [TBL] [Abstract][Full Text] [Related]
11. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276 [TBL] [Abstract][Full Text] [Related]
12. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release. Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816 [TBL] [Abstract][Full Text] [Related]
13. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses. Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399 [No Abstract] [Full Text] [Related]
14. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery. Shinde UA; Joshi PN; Jain DD; Singh K Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of Hou X; Zhang W; He M; Lu Y; Lou K; Gao F Asian J Pharm Sci; 2017 Nov; 12(6):558-568. PubMed ID: 32104369 [No Abstract] [Full Text] [Related]
16. Immunoenhancement effects of chitosan-modified ginseng stem-leaf saponins-encapsulated cubosomes as an ajuvant. Qiu T; Gu P; Wusiman A; Ni H; Xu S; Zhang Y; Zhu T; He J; Liu Z; Hu Y; Liu J; Wang D Colloids Surf B Biointerfaces; 2021 Aug; 204():111799. PubMed ID: 33971614 [TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Zhang P; Liu X; Hu W; Bai Y; Zhang L Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746 [TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia. Liu S; Ho PC J Pharm Pharmacol; 2017 Nov; 69(11):1495-1501. PubMed ID: 28809432 [TBL] [Abstract][Full Text] [Related]
19. Chitosan based nanoparticles as protein carriers for efficient oral antigen delivery. Gao P; Xia G; Bao Z; Feng C; Cheng X; Kong M; Liu Y; Chen X Int J Biol Macromol; 2016 Oct; 91():716-23. PubMed ID: 27287772 [TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro release study of β-cyclodextrin/chitosan nanoparticles loaded Cinnamomum zeylanicum essential oil. Matshetshe KI; Parani S; Manki SM; Oluwafemi OS Int J Biol Macromol; 2018 Oct; 118(Pt A):676-682. PubMed ID: 29959997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]